BIOMARIN PHARMACEUTICAL INC cotiza a 54.26 USD y tiene una capitalización bursátil de $10.5B. En los últimos 12 meses ha facturado $3.4B con un margen de flujo de caja libre del 22.5%. Cotiza a 14.2 veces su flujo de caja libre (P/FCF) y a un PER de 143.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an e…
| Métrica | BMRN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 77.7% | 57.0% | +20.7% |
| Operating Margin | 12.7% | -38.6% | +51.3% |
| Net Margin | 10.8% | -33.6% | +44.4% |
| FCF Margin | 22.5% | -13.9% | +36.4% |
| ROE | 5.7% | -40.4% | +46.1% |
| ROA | 4.6% | -32.0% | +36.6% |
| Current Ratio | 5.21 | 2.84 | +2.37 |
| Debt / Equity | — | 0.28 | — |